Assessing a Dose ‐Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
Condition: Polycystic Kidney Diseases Intervention: Drug: Hydralazine Sponsor: University of Kansas Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2018 Category: Research Source Type: clinical trials